Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Alexandre Bart

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Revue Medicale Suisse|May 7, 2020
[Medical students at the bedside of COVID-19 patients : motivations and challenges]Oriane Aebischer, Raphaël Porret, Victoria Pawlowska, et al.
European Journal of Immunology|March 5, 2013
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active diseaseVirginie Rozot, Selena Vigano, Jesica Mazza-Stalder, et al.
European Journal of Immunology|August 30, 2012
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.
Nature Medicine|February 22, 2011
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active diseaseAlexandre Harari, Virginie Rozot, Felicitas Bellutti Enders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosisVirginie Rozot, Amelio Patrizia, Selena Vigano, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Trials|November 25, 2025
Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial)Krisztina Hosszu-Fellous, Antoine Poncet, Ana Rita Goncalves Cabecinhas, et al.
Journal of Virology|March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogensPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Revue Medicale Suisse|April 30, 2020
[Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]Antoine Garnier, Julien Vaucher, Christophe Bianchi, et al.
Biomed Research International|November 18, 2020
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University HospitalEleftheria Kampouri, Paraskevas Filippidis, Benjamin Viala, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Revue Medicale Suisse|May 7, 2020
[Medical students at the bedside of COVID-19 patients : motivations and challenges]Oriane Aebischer, Raphaël Porret, Victoria Pawlowska, et al.
European Journal of Immunology|March 5, 2013
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active diseaseVirginie Rozot, Selena Vigano, Jesica Mazza-Stalder, et al.
European Journal of Immunology|August 30, 2012
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.
Nature Medicine|February 22, 2011
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active diseaseAlexandre Harari, Virginie Rozot, Felicitas Bellutti Enders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosisVirginie Rozot, Amelio Patrizia, Selena Vigano, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Trials|November 25, 2025
Antiviral treatment in adult patients hospitalized for influenza: study protocol for a multi-center, randomized, placebo-controlled trial on the efficacy of baloxavir marboxil to reduce time to clinical improvement and the risk for severe complications (the INFLUENT trial)Krisztina Hosszu-Fellous, Antoine Poncet, Ana Rita Goncalves Cabecinhas, et al.
Journal of Virology|March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogensPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Revue Medicale Suisse|April 30, 2020
[Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]Antoine Garnier, Julien Vaucher, Christophe Bianchi, et al.
Biomed Research International|November 18, 2020
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University HospitalEleftheria Kampouri, Paraskevas Filippidis, Benjamin Viala, et al.
Pageof 10